Extracellular RNAs: development as biomarkers of human disease
Quinn, Joseph F.
Freedman, Jane E.
Laurent, Louise C.
Carter, Bob S.
Keuren-Jensen, Kendall Van
Kalani, M. Yashar S.
Adelson, P. David
Saugstad, Julie A.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationQuinn, J. F., T. Patel, D. Wong, S. Das, J. E. Freedman, L. C. Laurent, B. S. Carter, et al. 2015. “Extracellular RNAs: development as biomarkers of human disease.” Journal of Extracellular Vesicles 4 (1): 10.3402/jev.v4.27495. doi:10.3402/jev.v4.27495. http://dx.doi.org/10.3402/jev.v4.27495.
AbstractTen ongoing studies designed to test the possibility that extracellular RNAs may serve as biomarkers in human disease are described. These studies, funded by the NIH Common Fund Extracellular RNA Communication Program, examine diverse extracellular body fluids, including plasma, serum, urine and cerebrospinal fluid. The disorders studied include hepatic and gastric cancer, cardiovascular disease, chronic kidney disease, neurodegenerative disease, brain tumours, intracranial haemorrhage, multiple sclerosis and placental disorders. Progress to date and the plans for future studies are outlined.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:22856945
- HMS Scholarly Articles